Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy

Epilepsia

Volumn 53, Issue 12, 2012, Pages 2172-2177

  Coppola, Giangennaro ^a   Fortunato, Delia ^b   Mainolfi, Ciro ^c   Porcaro, Francesco ^c   Roccaro, Davide ^c   Signoriello, Giuseppe ^b   Operto, Francesca Felicia ^a   Verrotti, Alberto ^d  

^a UNIVERSITY OF SALERNO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anticonvulsant drugs; Dual x ray absorptiometry; Osteopenia; Osteoporosis

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BENIGN CHILDHOOD EPILEPSY; BODY MASS; BONE DENSITY; CEREBRAL PALSY; CHILD; COMORBIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING EQUIPMENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INDEPENDENT VARIABLE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MULTIVARIATE ANALYSIS; ONSET AGE; OSTEOPENIA; OSTEOPOROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUADRIPLEGIA; SCHOOL CHILD;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH PLANNING; EPILEPSY; FEMALE; HUMANS; INTELLECTUAL DISABILITY; MALE; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 84870579876     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03639.x     Document Type: Article

References (42)

1. Angelopoulou N, Matziari C, Tsimaras V, Sakadamis A, Souftas V, Mandroukas K,. (2000) Bone mineral density in adults with Down's syndrome. Calcif Tissue Int 66: 176-180.
2. Baroncelli GI, Bertelloni S, Sodini F, Saggese G,. (2005) Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs 7: 295-323.
3. Beerhorst K, Huvers FC, Renier WO,. (2005) Severe early onset osteopenia and osteoporosis caused by antiepileptic drugs. J Med 63: 222-226.
4. Budden SS, Gunness ME,. (2003) Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies. J Child Neurol 18: 698-702.
5. Center J, Beange H, McEldfuff A,. (1998) People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard 103: 19-28.
6. Chung S, Ahn C,. (1994) Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain & Dev 16: 382-385.
7. Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, Laborde K, Souberbielle JC, Polak M,. (2011) Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr 75: 123-130.
8. Coppola G, Verrotti A, Mainolfi C, Auricchio G, Fortunato D, Operto FF, Pascotto A,. (2007) Bone mineral density in Angelman syndrome. Pediatr Neurol 37: 411-416.
9. Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF, Signoriello G, Pascotto A, Salvatore M,. (2009) Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia 50: 2140-2146.
10. Ecevit C, Aydogan A, Kavakli T, Altinoz S,. (2004) Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 31: 279-282.
11. Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A,. (2000) Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab 13: 933-999.
12. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G,. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58: 1348-1353.
13. González-Agüero A, Vicente-Rodríguez G, Moreno LA, Casajús JA,. (2011) Bone mass in male and female children and adolescents with Down syndrome. Osteoporos Int 22: 2151-2157.
14. Guo CY, Ronen GM, Atkinson SA,. (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 42: 1141-1147.
15. Haas RH, Dixon SD, Sartoris D, Hennessy MJ,. (1997) Osteopenia in Rett syndrome. J Pediatr 13: 771-774.
16. Henderson RC, Lin PP, Greene WB,. (1995) Bone-mineral density in children and adolescents who have spastic cerebral palsy. Bone Joint Surg Am 11: 1671-1681.
17. Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stallings VA, Stevenson RD,. (2002) Bone density and metabolism in children and adolescnets with moderate to severe cerebral palsy. Pediatrics 110 (1 Pt 1): e5.
18. Houlihan CM, Stevenson RD,. (2009) Bone density in cerebral palsy. Phys Med Rehabil Clin N Am 20: 493-508.
19. Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R,. (1971) Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J 4: 202-204.
20. Kafali G, Erselcan T, Tanzer F,. (1999) Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr 38: 93-98.
21. King W, Levine R, Schmidt R, Oestreich A, Heubi JE,. (2003) Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol 45: 12-16.
22. Lee JJ, Lyne ED, Kleerekoper M, Logan MS, Belfi RA,. (1989) Disorders of bone metabolism in severely handicapped children and young adults. Clin Orthop Relat Res 245: 297-302.
23. Lewiecki EM, Gordon CM, Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S, Bishop NJ, Leonard MB, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS,. (2008) Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int 19: 1369-1378.
24. McCloskey EV, Johansson H, Oden A, Kanis A,. (2009) From relative to absolute fracture risk calculation: the FRAX algorithm. Curr Osteoporos Rep 7: 77-83.
25. Medlinsky HL,. (1974) Rickets associated with anticonvulsant medication. Pediatrics 53: 91-95.
26. Mergler S, Evenhuis HM, Boot AM, De Man SA, Bindels-De Heus KG, Huijbers WA, Penning C,. (2009) Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review. Dev Med Child Neurol 51: 773-778.
27. Morijiri Y, Sato T,. (1981) Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child 56: 446-449.
28. Mugica I, Ansa J, Sistiaga F, Zabalza R, Zubillaga P, Merino A, Mojedano B, Vidal C,. (2002) Digital computerized absorptiometry in the diagnosis of osteoporosis in a group of the severely mentally retarded. Nutr Hosp 17: 213-218.
29. Petty SJ, O'Brien TJ, Wark JD,. (2007) Anti-epileptic medication and bone health. Osteoporos Int 8: 129-142.
30. Roende G, Ravn K, Fuglsang K, Andersen H, Nielsen JB, Brøndum-Nielsen K, Jensen JE,. (2011) DXA measurements in Rett syndrome reveal small bones with low bone mass. J Bone Miner Res 26: 2280-2286.
31. Samaniego E, Sheth RD,. (2007) Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 14: 196-200.
32. Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K,. (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57: 445-449.
33. Schrager S,. (2006) Epidemiology of osteoporosis in women with cognitive impairment. Ment Retard 44: 203-211.
34. Shaw NJ, White CP, Fraser WD, Rosenbloom L,. (1994) Osteopenia in cerebral palsy. Arch Dis Child 71: 235-238.
35. Sheth RD,. (2004) Bone health in pediatric epilepsy. Epilepsy Behav 5: S30-S35.
36. Sheth RD, Hermann BP,. (2007) Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 37: 250-254.
37. Srikanth R, Cassidy G, Joiner C, Teeluckdharry S,. (2011) Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities. J Intellect Disabil Res 55: 53-62.
38. Tandon N, Fall CH, Osmond C, Sachdev HP, Prabhakaran D, Ramakrishnan L, Dey Biswas SK, Ramji S, Khalil A, Geral T, Reddy KS, Barker DJ, Cooper C, Bhargawa SK,. (2012) Growth from birth to adulthood and peak bone mass and density data from the New Delhi Birth Cohort. Osteoporos Int Jan 12 [Epub ahead of print].
39. Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, Tsuhkahara Y, Miura M, Mayumi M,. (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int 44: 247-253.
40. Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F,. (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 43: 1488-1492.
41. Weisman Y, Fattal A, Eisenberg Z, Harel S, Spirer Z, Harell A,. (1979) Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy. Br Med J 2: 521-523.
42. Zhang J, Wang KX, Wei Y, Xu MH, Su JM, Bao YG, Zhao SY,. (2010) Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy. Zhongguo Dang Dai Er Ke Za Zhi 2: 96-98.